HUMULIN: payments to doctors
Payments that named HUMULIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 3,669
- Transactions
- 16,108
- Average per transaction
- $68
The per-transaction average — $68 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,669 providers the average total is $300, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $1,085,226 | 98.7% |
| Eli Lilly Export S.A. Puerto Rico Branch | $14,283 | 1.3% |
| Eli Lilly | $8 | 0.0% |